Literature DB >> 21701797

Relationship between psoriatic arthritis and moderate-severe psoriasis: analysis of a series of 166 psoriatic arthritis patients selected from a hospital population.

Noemi Busquets-Pérez1, Jesus Rodriguez-Moreno, Carmen Gómez-Vaquero, Joan M Nolla-Solé.   

Abstract

The aim of the study was to assess the prevalence of moderate to severe psoriasis (MS-P) in patients with psoriatic arthritis (PsA) and the relationship between MS-P and other variables related to arthritis. One hundred sixty-six consecutive patients with PsA periodically monitored at a university hospital's PsA unit in northeastern Spain were included in the study. Patients with psoriasis were classified as having MS-P when systemic treatment for skin was required. Clinical criteria for treatment indication was BSA >10 and/or PASI >14 and/or psoriasis affecting a very sensitive area of the body. Demographic and clinical data related to arthritis were assessed, including PsA pattern, age of onset of psoriasis and arthritis, disease activity index, and treatment required over the course of the disease. Moderate-severe psoriasis were more prevalent in women (p = 0.027). One hundred nine patients (65.7%) had psoriatic nail disease, and MS-P was more frequent in these patients (40 (77%) vs. 69 (61%), p = 0.028). Patients with spondyloarthropathy were significantly associated with MS-P (7 (16%) vs. 3 (3%), p = 0.014). No statistical association was observed between severe psoriasis and the age of onset of psoriasis or arthritis, involvement of distal interphalangeal joints, laboratory findings (HLA B27, RF), functional class, or disease activity indices. We report a high prevalence of severe psoriasis among patients with psoriatic arthritis, higher in women and patients with psoriatic nail disease and axial spondyloarthropathy.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21701797     DOI: 10.1007/s10067-011-1787-1

Source DB:  PubMed          Journal:  Clin Rheumatol        ISSN: 0770-3198            Impact factor:   2.980


  21 in total

1.  [Functional impairment in psoriatic arthritis. Multicentric study of 343 patients].

Authors:  Delia Reina Sanz; Jordi del Blanco; Maria Bonet; Carmen Castaño; Teresa Clavaguera; Lourdes Mateo; Daniel Roig Vilaseca; José M Ruiz; Jesús Rodríguez Moreno
Journal:  Med Clin (Barc)       Date:  2007-07-07       Impact factor: 1.725

2.  Psoriatic arthritis in severe psoriasis.

Authors:  H Little; J N Harvie; R S Lester
Journal:  Can Med Assoc J       Date:  1975-02-08       Impact factor: 8.262

3.  Modified disease activity scores that include twenty-eight-joint counts. Development and validation in a prospective longitudinal study of patients with rheumatoid arthritis.

Authors:  M L Prevoo; M A van 't Hof; H H Kuper; M A van Leeuwen; L B van de Putte; P L van Riel
Journal:  Arthritis Rheum       Date:  1995-01

4.  Psoriatic spondylitis: a clinical, radiological, and scintiscan survey.

Authors:  D Barraclough; A S Russell; J S Percy
Journal:  J Rheumatol       Date:  1977       Impact factor: 4.666

5.  Severe psoriasis--oral therapy with a new retinoid.

Authors:  T Fredriksson; U Pettersson
Journal:  Dermatologica       Date:  1978

6.  Extended report: nail disease in psoriatic arthritis--clinically important, potentially treatable and often overlooked.

Authors:  L Williamson; N Dalbeth; J L Dockerty; B C Gee; R Weatherall; B P Wordsworth
Journal:  Rheumatology (Oxford)       Date:  2004-04-27       Impact factor: 7.580

7.  A new approach to defining functional ability in ankylosing spondylitis: the development of the Bath Ankylosing Spondylitis Functional Index.

Authors:  A Calin; S Garrett; H Whitelock; L G Kennedy; J O'Hea; P Mallorie; T Jenkinson
Journal:  J Rheumatol       Date:  1994-12       Impact factor: 4.666

8.  Psoriatic arthritis: outcome of disease subsets and relationship of joint disease to nail and skin disease.

Authors:  S M Jones; J B Armas; M G Cohen; C R Lovell; G Evison; N J McHugh
Journal:  Br J Rheumatol       Date:  1994-09

9.  Dermatological manifestations in psoriatic arthritis: a follow-up study.

Authors:  V Wright; M C Roberts; A G Hill
Journal:  Acta Derm Venereol       Date:  1979       Impact factor: 4.437

10.  The epidemiology of joint complaints in patients with psoriasis.

Authors:  R S Stern
Journal:  J Rheumatol       Date:  1985-04       Impact factor: 4.666

View more
  2 in total

Review 1.  Axial psoriatic arthritis: an intriguing clinical entity or a subset of an intriguing disease?

Authors:  Ennio Lubrano; Antonio Spadaro
Journal:  Clin Rheumatol       Date:  2012-05-03       Impact factor: 2.980

2.  A head-to-head comparison of the efficacy and safety of ixekizumab and adalimumab in biological-naïve patients with active psoriatic arthritis: 24-week results of a randomised, open-label, blinded-assessor trial.

Authors:  Philip J Mease; Josef S Smolen; Frank Behrens; Peter Nash; Soyi Liu Leage; Lingnan Li; Hasan Tahir; Melinda Gooderham; Eswar Krishnan; Hong Liu-Seifert; Paul Emery; Sreekumar G Pillai; Philip S Helliwell
Journal:  Ann Rheum Dis       Date:  2019-09-28       Impact factor: 19.103

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.